Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium | 74 | 2023 | 288 | 10.880 |
Why?
|
| Muscle, Skeletal | 53 | 2023 | 201 | 9.420 |
Why?
|
| Calcium Signaling | 33 | 2018 | 91 | 5.810 |
Why?
|
| Sarcoplasmic Reticulum | 38 | 2017 | 141 | 4.540 |
Why?
|
| Animals | 91 | 2023 | 2092 | 3.210 |
Why?
|
| Calsequestrin | 13 | 2017 | 31 | 2.990 |
Why?
|
| Malignant Hyperthermia | 5 | 2023 | 16 | 2.780 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 24 | 2023 | 108 | 2.660 |
Why?
|
| Muscle Contraction | 16 | 2023 | 52 | 2.490 |
Why?
|
| Muscle Fibers, Skeletal | 21 | 2023 | 42 | 2.480 |
Why?
|
| Calcium Channels | 25 | 2019 | 88 | 1.910 |
Why?
|
| Caffeine | 11 | 2023 | 38 | 1.660 |
Why?
|
| Membrane Potentials | 30 | 2013 | 130 | 1.580 |
Why?
|
| Muscles | 15 | 2006 | 49 | 1.540 |
Why?
|
| Myocytes, Cardiac | 8 | 2018 | 57 | 1.540 |
Why?
|
| Myocardium | 13 | 2017 | 81 | 1.530 |
Why?
|
| Ion Channel Gating | 20 | 2017 | 109 | 1.480 |
Why?
|
| Hyperglycemia | 2 | 2023 | 13 | 1.390 |
Why?
|
| Microscopy, Confocal | 17 | 2013 | 51 | 1.350 |
Why?
|
| Rana pipiens | 31 | 2012 | 50 | 1.280 |
Why?
|
| Mice | 22 | 2022 | 760 | 1.250 |
Why?
|
| Models, Biological | 21 | 2013 | 191 | 1.070 |
Why?
|
| Fluorescent Dyes | 7 | 2013 | 24 | 0.920 |
Why?
|
| Cytosol | 10 | 2012 | 32 | 0.830 |
Why?
|
| Glucose | 2 | 2023 | 24 | 0.810 |
Why?
|
| Cell Membrane | 8 | 2011 | 63 | 0.790 |
Why?
|
| Computer Simulation | 5 | 2019 | 90 | 0.770 |
Why?
|
| Halothane | 2 | 2023 | 6 | 0.750 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 7 | 0.730 |
Why?
|
| In Vitro Techniques | 21 | 2012 | 117 | 0.720 |
Why?
|
| Patch-Clamp Techniques | 20 | 2011 | 72 | 0.710 |
Why?
|
| Homeostasis | 3 | 2012 | 35 | 0.690 |
Why?
|
| Excitation Contraction Coupling | 3 | 2017 | 8 | 0.670 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 29 | 0.610 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2012 | 6 | 0.610 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 40 | 0.610 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 24 | 0.580 |
Why?
|
| Calcium Channels, L-Type | 5 | 2015 | 42 | 0.570 |
Why?
|
| Microscopy, Fluorescence | 5 | 2022 | 43 | 0.560 |
Why?
|
| Cells, Cultured | 12 | 2018 | 275 | 0.560 |
Why?
|
| Muscular Diseases | 2 | 2015 | 12 | 0.550 |
Why?
|
| Signal Transduction | 7 | 2018 | 246 | 0.540 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 17 | 0.530 |
Why?
|
| Electrophysiology | 19 | 2008 | 74 | 0.530 |
Why?
|
| Humans | 20 | 2023 | 12240 | 0.520 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 28 | 0.520 |
Why?
|
| Cell Membrane Permeability | 4 | 2011 | 29 | 0.510 |
Why?
|
| Kinetics | 15 | 2013 | 110 | 0.470 |
Why?
|
| Action Potentials | 8 | 2013 | 64 | 0.460 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 19 | 0.440 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 6 | 0.430 |
Why?
|
| Membrane Proteins | 2 | 2023 | 69 | 0.410 |
Why?
|
| Muscle Proteins | 2 | 2015 | 20 | 0.410 |
Why?
|
| Ryanodine | 2 | 2012 | 16 | 0.400 |
Why?
|
| Carrier Proteins | 2 | 2015 | 45 | 0.400 |
Why?
|
| Hypothermia | 1 | 2013 | 4 | 0.390 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 4 | 0.380 |
Why?
|
| Neurons | 1 | 2012 | 164 | 0.340 |
Why?
|
| Electric Stimulation | 12 | 2004 | 35 | 0.340 |
Why?
|
| Rats | 11 | 2016 | 407 | 0.340 |
Why?
|
| Protein Isoforms | 5 | 2022 | 22 | 0.320 |
Why?
|
| Rabbits | 9 | 2013 | 110 | 0.280 |
Why?
|
| Algorithms | 7 | 2017 | 169 | 0.280 |
Why?
|
| Central Nervous System Stimulants | 3 | 2000 | 29 | 0.280 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 6 | 0.270 |
Why?
|
| Protein Binding | 3 | 2019 | 70 | 0.270 |
Why?
|
| Magnesium | 6 | 2012 | 34 | 0.250 |
Why?
|
| Mammals | 2 | 2023 | 11 | 0.250 |
Why?
|
| Ion Channels | 4 | 2009 | 130 | 0.240 |
Why?
|
| Adult | 5 | 2020 | 3557 | 0.230 |
Why?
|
| Kidney | 3 | 2003 | 87 | 0.230 |
Why?
|
| Phosphorylation | 4 | 2020 | 78 | 0.220 |
Why?
|
| Sodium Compounds | 3 | 1993 | 4 | 0.220 |
Why?
|
| Perchlorates | 3 | 1993 | 5 | 0.220 |
Why?
|
| Image Enhancement | 1 | 2005 | 25 | 0.220 |
Why?
|
| Mutation | 3 | 2015 | 175 | 0.220 |
Why?
|
| Neuromuscular Junction | 3 | 2009 | 5 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 179 | 0.220 |
Why?
|
| Heart | 3 | 2003 | 42 | 0.210 |
Why?
|
| Calcium Channel Blockers | 3 | 2010 | 18 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2010 | 170 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2007 | 225 | 0.190 |
Why?
|
| Egtazic Acid | 7 | 2011 | 10 | 0.190 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 7 | 0.190 |
Why?
|
| Heart Ventricles | 3 | 2013 | 50 | 0.190 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 9 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 16 | 0.190 |
Why?
|
| Tetracaine | 5 | 2007 | 8 | 0.180 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2002 | 1 | 0.180 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 4 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2002 | 35 | 0.170 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 24 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 61 | 0.170 |
Why?
|
| Anura | 5 | 2004 | 15 | 0.170 |
Why?
|
| Isoproterenol | 2 | 2013 | 13 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2013 | 12 | 0.160 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glycogen | 1 | 2020 | 10 | 0.160 |
Why?
|
| Time Factors | 5 | 2005 | 695 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2020 | 53 | 0.150 |
Why?
|
| Dihydropyridines | 3 | 1998 | 5 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2013 | 21 | 0.140 |
Why?
|
| Male | 4 | 2018 | 6815 | 0.140 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 8 | 0.140 |
Why?
|
| Phenotype | 2 | 2017 | 157 | 0.140 |
Why?
|
| Species Specificity | 4 | 2005 | 28 | 0.130 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 1 | 0.130 |
Why?
|
| Synaptic Transmission | 2 | 1993 | 14 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 338 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 73 | 0.120 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1997 | 12 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2015 | 16 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 19 | 0.110 |
Why?
|
| Electric Conductivity | 5 | 1997 | 56 | 0.110 |
Why?
|
| Barium | 4 | 1998 | 8 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2009 | 81 | 0.110 |
Why?
|
| Intracellular Membranes | 2 | 1991 | 13 | 0.110 |
Why?
|
| Middle Aged | 2 | 2020 | 4043 | 0.110 |
Why?
|
| Aged | 2 | 2020 | 4000 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 182 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2010 | 14 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2011 | 10 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 5 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 26 | 0.090 |
Why?
|
| Female | 3 | 2018 | 6974 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 1992 | 23 | 0.090 |
Why?
|
| Binding Sites | 2 | 2009 | 39 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 4 | 0.090 |
Why?
|
| Ventricular Function | 1 | 1992 | 4 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 8 | 0.090 |
Why?
|
| Cell Line | 3 | 2003 | 150 | 0.090 |
Why?
|
| Cats | 1 | 2012 | 15 | 0.090 |
Why?
|
| Biophysical Phenomena | 2 | 2002 | 21 | 0.090 |
Why?
|
| Biophysics | 2 | 2002 | 25 | 0.090 |
Why?
|
| Nitrendipine | 1 | 1991 | 2 | 0.090 |
Why?
|
| Mitochondria, Muscle | 1 | 2011 | 3 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2011 | 8 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 23 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 1991 | 5 | 0.090 |
Why?
|
| Saponins | 2 | 2006 | 2 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 81 | 0.090 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 4 | 0.080 |
Why?
|
| Xanthenes | 3 | 2000 | 3 | 0.080 |
Why?
|
| Aniline Compounds | 3 | 2000 | 14 | 0.080 |
Why?
|
| Buffers | 1 | 2010 | 5 | 0.080 |
Why?
|
| Anesthetics, Local | 2 | 2003 | 45 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 97 | 0.080 |
Why?
|
| Feedback | 3 | 1997 | 17 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mitochondria | 1 | 2009 | 34 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2009 | 12 | 0.080 |
Why?
|
| Metals, Alkali | 1 | 1989 | 1 | 0.080 |
Why?
|
| Metals, Alkaline Earth | 1 | 1989 | 1 | 0.080 |
Why?
|
| Neutrophils | 1 | 2009 | 58 | 0.070 |
Why?
|
| Guinea Pigs | 3 | 1993 | 19 | 0.070 |
Why?
|
| Basophils | 1 | 2008 | 4 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 8 | 0.070 |
Why?
|
| Proton Pumps | 1 | 2008 | 10 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2008 | 20 | 0.070 |
Why?
|
| Chelating Agents | 2 | 2011 | 11 | 0.070 |
Why?
|
| Diffusion | 1 | 2008 | 17 | 0.070 |
Why?
|
| Lipid Bilayers | 4 | 2003 | 47 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 46 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 218 | 0.070 |
Why?
|
| Ranidae | 3 | 1991 | 3 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2007 | 4 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 10 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 28 | 0.060 |
Why?
|
| Biological Transport | 2 | 1999 | 23 | 0.060 |
Why?
|
| Markov Chains | 2 | 2002 | 15 | 0.060 |
Why?
|
| Thermodynamics | 2 | 2002 | 29 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 2 | 0.060 |
Why?
|
| Solutions | 1 | 2005 | 11 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2005 | 15 | 0.060 |
Why?
|
| Organelles | 1 | 2005 | 2 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 18 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 38 | 0.060 |
Why?
|
| Naphthalenesulfonates | 1 | 2004 | 1 | 0.050 |
Why?
|
| Phenolsulfonphthalein | 1 | 2004 | 1 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2004 | 5 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2003 | 9 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 5 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 29 | 0.050 |
Why?
|
| Rana catesbeiana | 2 | 2003 | 8 | 0.050 |
Why?
|
| Extracellular Space | 2 | 1996 | 9 | 0.050 |
Why?
|
| Oscillometry | 1 | 2002 | 4 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2002 | 60 | 0.050 |
Why?
|
| Probability | 2 | 1992 | 45 | 0.040 |
Why?
|
| Necrosis | 1 | 2002 | 10 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2002 | 28 | 0.040 |
Why?
|
| Fever | 1 | 2002 | 18 | 0.040 |
Why?
|
| Biomarkers | 2 | 2017 | 294 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 12 | 0.040 |
Why?
|
| Pain | 1 | 2002 | 193 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 3 | 0.040 |
Why?
|
| Artifacts | 1 | 1999 | 12 | 0.040 |
Why?
|
| Benzopyrans | 2 | 2009 | 6 | 0.040 |
Why?
|
| Xenopus | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 17 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 16 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 18 | 0.040 |
Why?
|
| Diastole | 2 | 2010 | 24 | 0.040 |
Why?
|
| Base Sequence | 1 | 1998 | 57 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 80 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 57 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 100 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1998 | 157 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 47 | 0.030 |
Why?
|
| Platelet Count | 1 | 2017 | 6 | 0.030 |
Why?
|
| Spain | 1 | 2017 | 4 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 8 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 30 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Mannose | 1 | 2016 | 1 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 88 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 59 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 12 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 55 | 0.030 |
Why?
|
| Sodium | 2 | 1997 | 33 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 54 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 209 | 0.030 |
Why?
|
| Perfusion | 1 | 1996 | 10 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 277 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 320 | 0.030 |
Why?
|
| Rana esculenta | 1 | 1996 | 2 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 12 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 12 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 16 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 29 | 0.030 |
Why?
|
| Membranes | 1 | 1995 | 7 | 0.030 |
Why?
|
| Child | 1 | 2017 | 614 | 0.030 |
Why?
|
| Ion Transport | 1 | 1994 | 21 | 0.030 |
Why?
|
| Chlorides | 1 | 1994 | 17 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 863 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 989 | 0.030 |
Why?
|
| Cadmium | 1 | 1993 | 7 | 0.030 |
Why?
|
| Isradipine | 1 | 1993 | 2 | 0.020 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 1993 | 2 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 3 | 0.020 |
Why?
|
| Edetic Acid | 1 | 1993 | 2 | 0.020 |
Why?
|
| Cations | 1 | 1993 | 12 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 59 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 5 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1992 | 6 | 0.020 |
Why?
|
| Gallopamil | 1 | 1992 | 6 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1478 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1992 | 8 | 0.020 |
Why?
|
| Mathematics | 1 | 1991 | 25 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 15 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 1991 | 6 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 1991 | 5 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1991 | 14 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 2 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 12 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1991 | 297 | 0.020 |
Why?
|
| Ruthenium Compounds | 1 | 2009 | 2 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2009 | 2 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 4 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 6 | 0.020 |
Why?
|
| Naphthols | 1 | 2009 | 3 | 0.020 |
Why?
|
| Rhodamines | 1 | 2009 | 4 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 5 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1989 | 1 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 24 | 0.020 |
Why?
|
| Protons | 1 | 2009 | 43 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 3 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 5 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 9 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 5 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 19 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 21 | 0.020 |
Why?
|
| Colforsin | 1 | 2007 | 8 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2007 | 10 | 0.020 |
Why?
|
| Calmodulin | 1 | 2007 | 5 | 0.020 |
Why?
|
| Benzylamines | 1 | 2007 | 11 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2007 | 22 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 42 | 0.020 |
Why?
|
| Heart Failure | 1 | 2007 | 77 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 43 | 0.010 |
Why?
|
| Potassium | 1 | 2003 | 32 | 0.010 |
Why?
|
| Calibration | 1 | 2002 | 8 | 0.010 |
Why?
|
| Biotransformation | 1 | 1997 | 4 | 0.010 |
Why?
|
| Myofibrils | 1 | 1988 | 5 | 0.000 |
Why?
|